Related by context. All words. (Click for frequent words.) 66 asymptomatic PAD 65 perimenopausal women 65 elevated LDL cholesterol 65 CVD mortality 64 anovulatory infertility 64 lobular cancer 63 abnormal lipid 63 coronary calcification 63 abnormal lipid levels 63 polyp recurrence 63 fasting insulin 63 thyrotropin levels 63 MetS 62 recurrent UTI 62 colorectal neoplasia 62 confidence interval #.#-#.# 62 fasting glucose levels 62 hydroxyvitamin D levels 62 elevated fasting glucose 62 advanced adenomas 62 subclinical hyperthyroidism 62 psychiatric comorbidities 62 nonobese 61 gallstone disease 61 multivariable adjusted 61 T1DM 61 nondepressed 61 plasma homocysteine levels 61 transferrin saturation 61 lobular breast cancer 61 endometriosis ovarian cysts 61 elevated uric acid 61 umol L 61 chlamydial infection 61 postmenopausal breast cancer 61 atypical hyperplasia 61 fibroids endometriosis 61 waist circumferences 61 cotinine levels 61 mammographic density 61 recurrent VTE 60 highest quintile 60 fetal chromosomal 60 hip BMD 60 sociodemographic characteristics 60 serum vitamin D 60 gestational diabetes mellitus 60 lifetime abstainers 60 abdominal adiposity 60 venlafaxine Effexor 60 extrapyramidal symptoms 60 highest tertile 60 slow metabolizers 60 TEAEs 60 MMSE scores 60 dysglycemia 60 advanced adenoma 60 plasma homocysteine 60 mIU L 60 abnormal Pap test 60 elevated triglyceride levels 60 polycystic ovary syndrome PCOS 60 endometrial hyperplasia 60 aspirin NSAIDs 60 serum BDNF 60 shorter telomere length 60 pre eclamptic 60 BRCA2 mutations 60 BMI z 60 carotid IMT 59 neurodevelopmental impairment 59 urate levels 59 abdominal obesity 59 impaired fasting glucose 59 urinary calcium 59 irregular menstrual cycles 59 drank decaffeinated coffee 59 BRCA1 mutation carriers 59 onset diabetes mellitus 59 elevated triglycerides 59 nondrinkers 59 habitual snoring 59 autistic traits 59 bowel polyps 59 testicular germ cell 59 neurologic complications 59 severe periodontitis 59 lipid lowering medications 59 familial pancreatic cancer 59 baseline HbA1c 59 colorectal adenoma 59 serum IGF 59 elevated LDL 59 subclinical atherosclerosis 59 gestational hypertension 59 serum creatinine levels 59 multivariate adjustment 59 cardiovascular mortality 59 non aspirin NSAIDs 59 serum folate 59 prolonged QT interval 59 serum lipid levels 59 abnormal mammograms 59 nonvertebral fractures 59 Prehypertension 59 preterm deliveries 58 plasma folate 58 serum estradiol 58 neurocognitive function 58 #q#.# deletion syndrome 58 basal cell nevus syndrome 58 dietary calcium intake 58 colorectal adenomas 58 flavonoid intake 58 hemoglobin A1c HbA1c 58 albumin excretion 58 alanine aminotransferase ALT 58 triacylglycerol concentrations 58 depressive symptomatology 58 testicular tumors 58 nonpregnant women 58 Depressive symptoms 58 CHD CVD 58 moderate renal impairment 58 elevated ALT 58 prehypertensive 58 Premenopausal women 58 premenopausal 58 primary ovarian insufficiency 58 carotid stenosis 58 serum uric acid 58 prednisone prednisolone 58 lipid abnormalities 58 nonalcoholic steatohepatitis 58 nondiabetic 58 mm Hg diastolic 58 untreated sleep apnea 58 CHD mortality 58 narcolepsy cataplexy 58 PON1 activity 58 tanned indoors 58 fructose intolerance 58 NHANES III 58 invasive ductal 58 depressive symptoms 58 β blockers 58 arterial thickening 58 HIV HCV coinfected 58 GH deficiency 58 ductal cancer 58 atypical ductal hyperplasia 58 HbA 1c levels 58 hypoglycemic episodes 58 BRCA2 carriers 58 BRCA gene mutations 58 antenatal depression 58 TT genotype 58 untreated hypothyroidism 58 haemorrhagic stroke 57 menstrual irregularity 57 bivariate analyzes 57 Hb A1C 57 triglyceride concentrations 57 elevated CRP 57 PSADT 57 serum phosphate 57 recurrent venous thromboembolism 57 folate intake 57 mm Hg systolic 57 alanine aminotransferase 57 carotid atherosclerosis 57 vertebral fracture 57 postmenopausal hormone 57 fasting triglyceride levels 57 beta carotene supplementation 57 metabolic syndrome 57 SHBG levels 57 protein excretion 57 SRBD 57 glycated hemoglobin HbA1c 57 urinary cortisol 57 noncardiovascular mortality 57 microalbuminuria 57 hormone receptor negative 57 arterial thromboembolic events 57 endometrial cancers 57 dapagliflozin plus 57 serum calcium levels 57 HIV uninfected 57 renal impairment 57 distal colon cancer 57 glycosylated hemoglobin HbA1c 57 depressive symptom 57 breast endometrial 57 comorbid depression 57 recurrent atrial fibrillation 57 postoperative AF 57 #mg/dL [001] 57 postoperative delirium 57 suicide attempters 57 elevated bilirubin 57 Nonalcoholic Fatty Liver Disease 57 lowest tertile 57 Secondhand smoke exposure 57 postmenopause 57 untreated celiac disease 57 nonfasting triglycerides 57 hypercalciuria 57 abdominally obese 57 prepubertal 57 dietary glycemic index 57 plasma triglycerides 57 hypovitaminosis D 57 Moderate drinkers 57 ductal breast cancer 57 coronary artery calcification 57 recurrent wheezing 57 metabolic abnormalities 57 BRCA mutation 57 coinfected 57 aged ≥ 57 atypia 57 COPD exacerbation 57 adenoma recurrence 57 POAG 57 Heritability 57 APOE e4 57 mL/min/#.# m 2 57 proliferative diabetic retinopathy 57 diabetes mellitus DM 57 born preterm 57 androgen excess 57 Serious adverse reactions 57 baseline serum creatinine 57 nocturnal hypoglycemia 57 benign breast 57 shorter telomeres 57 normotensive 57 osteosarcomas 57 mild renal insufficiency 57 CARDIA 57 VLBW 57 Leitzmann 57 ovulatory infertility 57 severe asthma exacerbations 57 cardiac malformations 57 behavioral disinhibition 57 nonmelanoma skin cancer 57 amenorrhea 57 habitual snorers 56 System IPSS 56 spontaneous preterm birth 56 estrogen receptor negative 56 transaminase elevations 56 systolic BP 56 Chronic ITP 56 sociodemographic factors 56 comorbid anxiety 56 Framingham Offspring 56 nonfasting triglyceride levels 56 nonvertebral fracture 56 coronary artery calcium 56 anticonvulsant medications 56 parous women 56 subclinical hypothyroidism 56 specific antigen PSA 56 endometrial carcinoma 56 benazepril 56 atrophic gastritis 56 nonseminoma 56 oxycodone CR 56 premenopausal breast cancer 56 serum GGT 56 suicide ideation 56 tibolone 56 orofacial clefts 56 nondiabetic patients 56 hypoglycaemic episodes 56 SGPT 56 obesity sedentary lifestyle 56 CC genotype 56 impaired glucose metabolism 56 inflammatory biomarkers 56 NATRECOR R 56 p = .# [002] 56 C reactive protein 56 serum selenium 56 subsyndromal 56 APOE ε4 56 elevated creatinine 56 corticosteroid dose 56 intima media thickness 56 psychiatric morbidity 56 affective disorders 56 urinary BPA 56 cortisol concentrations 56 serum calcium 56 conventional antipsychotics 56 BLLs 56 comorbid ADHD 56 Suicidal ideation 56 HbA1c levels 56 cerebral infarction 56 severe hypoglycaemia 56 thromboembolic 56 Munk Olsen 56 URTI 56 serum PSA 56 BRCA carriers 56 ALT elevation 56 nondiabetics 56 T2DM 56 nmol l 56 acrylamide intake 56 antidiabetic medication 56 opioid dependent 56 poor metabolizers 56 artery calcification 56 vitamin D inadequacy 56 folate vitamin B 56 % CI #.#-#.# [008] 56 sugar sweetened soft drinks 56 nulliparous women 56 CARDIA study 56 trivial Klatsky 56 cryptorchidism 56 premature menopause 56 asthma rhinitis 56 flutamide 56 underwent coronary angiography 56 obese adolescents 56 HbA 1c 56 estrogen progestin therapy 56 frequently benign tumor 56 BRCA mutation carriers 56 gallbladder disease 56 systolic blood pressures 56 hypophosphatemia 56 HER2 expression 56 CIN3 56 rheumatoid factor 56 enamel defects 56 transaminase levels 56 recurrent miscarriage 56 impaired glucose tolerance 56 undergone radical prostatectomy 56 Winkelmayer 56 advanced neoplasia 56 acarbose 56 spontaneous preterm delivery 55 phthalate metabolites 55 folic acid intake 55 adiponectin concentrations 55 drank pomegranate juice 55 abnormal Pap smear 55 MMSE score 55 prescribed statins 55 Sociodemographic 55 postmenopausal hormone replacement 55 adiponectin levels 55 cardiovascular disease hypertension 55 hippocampal volume 55 Heavy menstrual bleeding 55 mmHg diastolic 55 serum testosterone 55 femoral neck BMD 55 neutrophil counts 55 albuminuria 55 affective psychoses 55 undetectable viral 55 mcg dL 55 postoperative mortality 55 gestational diabetes mellitus GDM 55 PREZISTA r arm 55 BMI percentile 55 de ath 55 #q# deletion syndrome 55 perinatal complications 55 fatal IHD 55 #OHD levels 55 Cortisol levels 55 dietary sodium 55 depression irritability 55 histological subtype 55 internalizing disorders 55 undergone bariatric surgery 55 bronchopulmonary dysplasia 55 carotid plaques 55 neurodevelopmental outcomes 55 baseline A1C 55 #mmHg [002] 55 internalizing behaviors 55 psychiatric comorbidity 55 elevated prolactin 55 rectal gonorrhea 55 comorbid psychiatric 55 Excessive daytime sleepiness 55 nulliparous 55 androgen deficiency 55 NAFLD 55 prolactin levels 55 homocysteine concentrations 55 Pischon 55 bioavailable testosterone 55 Reefhuis 55 urinary symptoms 55 overt hypothyroidism 55 uncontrolled hypertension 55 metabolic acidosis 55 decreased libido 55 nonfatal MI 55 seropositivity 55 nephrolithiasis 55 undergo bariatric surgery 55 suicidality 55 nonsignificant difference 55 detectable BPA 55 Erythropoietic therapies may 55 intermittent exotropia 55 thyroid hormone levels 55 unfavorable genotypes 55 noncarriers 55 urolithiasis 55 non fasting triglycerides 55 binary restenosis 55 tic severity 55 faulty BRCA2 gene 55 prescribed opioids 55 VTEs 55 glycated hemoglobin levels 55 preoperative PSA 55 HER2 overexpression 55 cholinergic tone 55 aminotransferases 55 thiazide 55 deep venous thromboses 55 μg dL 55 leucopenia 55 Triglyceride levels 55 fasting glucose 55 GH deficient 55 undergoing bariatric surgery 55 asthma exacerbation 55 irregular menstrual periods 55 airway responsiveness 55 serum urate levels 55 nonalcoholic steatohepatitis NASH 55 thiazides 55 fetal malformations 55 bacteriuria 55 underwent prostatectomy 55 exposed prenatally 55 hereditary predisposition 55 abnormal mammogram 55 neurocognitive functioning 55 hydroxyvitamin D concentrations 55 glucose intolerance 55 concomitant medications 55 elevated hsCRP 55 citalopram Celexa 55 cognitive impairment 55 Cognitive Impairment 55 body fatness 55 prolactin elevation 55 dietary questionnaires 55 subclinical cardiovascular disease 55 type2 diabetes 55 prostate pancreatic 55 white matter hyperintensities 55 pre menopausal 55 loop diuretics 55 uncontrolled asthma 55 PBDE chemicals 55 aortic atherosclerosis 55 postmenopausal hormones 55 attention-deficit/hyperactivity disorder ADHD 55 CIN2 + 55 UGT#A# * 55 univariate analyzes 55 lipid elevations 55 serum homocysteine 55 serum leptin 55 metabolic syndrome clustering 55 PCA3 scores 55 autonomic dysfunction 55 Complication rates 55 ATACAND 55 seroconverted 55 microscopic hematuria 55 chlamydia infections 55 renal cell carcinomas 55 primary hypercholesterolemia 55 malondialdehyde 55 noncardiovascular 55 pancreatic prostate 55 macrovascular events 55 severe obstructive sleep 55 QIDS SR 55 nonadherence 55 Impaired glucose tolerance 55 activity MAOA 55 lymphatic cancers 54 tumor histology 54 cardiorespiratory fitness 54 troponin T 54 folic acid takers 54 hypertension diabetes mellitus 54 undergone hysterectomy 54 LUTS 54 hematologic abnormalities 54 Nonalcoholic fatty liver 54 HBV infections 54 Uterine cancer 54 BRCA1 mutations 54 salivary cortisol 54 nonfasting 54 drank caffeinated 54 prostate abnormalities 54 overt hepatic encephalopathy HE 54 calcium intakes 54 serum parathyroid hormone 54 oesophageal adenocarcinoma 54 HIV seroconversion 54 maintaining cardiorespiratory fitness 54 elevated LDH 54 HOMA IR 54 impaired cognition 54 rimonabant #mg 54 del 5q MDS 54 N telopeptide 54 steroid dexamethasone 54 salivary flow 54 lipid parameters 54 telomere lengths 54 affective psychosis 54 serum folate concentrations 54 prostate cancer CaP 54 Hypogonadism 54 symptomatic intracerebral hemorrhage 54 hyperphenylalaninemia HPA due 54 parkinsonism 54 elevated serum creatinine 54 mcg dl 54 confidence intervals CIs 54 folate deficiency 54 hemoglobin A1c levels 54 HbA1C levels 54 irregular menses 54 chronic periodontitis 54 A1c levels 54 alcoholic fatty liver 54 preserved ejection fraction 54 normal birthweight 54 cardio metabolic 54 mmHg systolic 54 oral antidiabetic medication 54 unprotected vaginal 54 HGPIN 54 gestational glucose intolerance 54 newer antipsychotics 54 vulvovaginal atrophy 54 hsCRP levels 54 cardio respiratory fitness 54 genital ulcers 54 smoldering myeloma 54 cardiovascular disease 54 familial AF 54 thiazide diuretics 54 unexplained stillbirth 54 cerebral microbleeds 54 Avandia Actos 54 undergoing radical prostatectomy 54 HNSCC 54 triglyceride levels 54 paroxetine Paxil 54 adenomatous polyps 54 nonadherent 54 LDL cholesterol concentrations 54 oxygen desaturation 54 polycystic ovary syndrome 54 nanograms milliliter 54 lichen planus 54 asymptomatic hypothyroidism 54 testosterone supplementation 54 HRQOL 54 VaD 54 urinary oxalate 54 hypoglycemic events 54 systolic dysfunction 54 Univariate analysis 54 chronic prostatitis 54 myopathy rhabdomyolysis 54 decompensated cirrhosis 54 physiological arousal 54 breast tenderness 54 cholesterol triglyceride 54 Calcium intake 54 underwent CABG 54 gastroesophageal reflux GERD 54 lobular carcinoma 54 leukopenia 54 intensive statin therapy 54 intravenous bisphosphonates 54 Testosterone deficiency 54 menthol smokers 54 #.#mmol L [002] 54 glomerular filtration 54 venous thrombosis 54 fasting serum 54 colorectal polyps 54 nonmelanoma skin cancers 54 ventricular tachyarrhythmia 54 oral hypoglycemic agents 54 relapsed MM 54 modifiable lifestyle 54 tHcy 54 Genetic variants 54 carotid artery intima media 54 Inhibin B 54 milligrams deciliter 54 external genital lesions 54 fructose diet 54 angina chest 54 HER2 positive cancers 54 Myelodysplastic syndromes MDS 54 colorectal cancer incidence 54 % CI #.#-#.# [006] 54 oral clefts 54 PLX STROKE targeting 54 sugar sweetened cola 54 pentoxifylline 54 neurocognitive deficits 54 mineral density 54 Fasting plasma glucose 54 HBeAg negative patients 54 comorbid disorders 54 #.#ng/ml 54 suboptimal adherence 54 limiting generalizability 54 overactive bladder symptoms 54 postoperative complications 54 acromegalic patients 54 thiopurine 54 psychotic illnesses 54 buprenorphine implants 54 WARNINGS Myopathy Rhabdomyolysis 54 severe renal impairment 54 odds ratios ORs 54 folate concentrations 54 BRCA2 mutation 54 creatinine levels 54 valproate 54 fluoxetine Prozac 54 atopic 54 potassium sparing diuretics 54 estimated glomerular filtration 54 hematopoietic cancers 54 metabolic syndrome MetS 54 AAT deficiency 54 untreated OSA 54 hypercholesterolaemia 54 suicidal ideation 54 obstetric complications 54 elevated cholesterol 54 atherogenic dyslipidemia 54 overweight sedentary 54 #q# deletion 54 renal scarring 54 systolic hypertension 54 overt nephropathy 54 androgenic alopecia 54 HIV lipodystrophy 54 Waist Circumference 54 hirsutism 54 ultra rapid metabolizers 54 underwent bariatric surgery 54 breast cancer recurrences 54 Heavy snorers 54 venous thromboembolic events 54 antihypertensive medications 54 dyslipidaemia 54 % CI #.#-#.# [004] 54 nonexposed 54 recurrent DVT 54 brain shrinkage 54 pT3 54 colon rectal 54 follicular phase 54 adrenal function 54 abnormal ejaculation 54 tricyclic antidepressants 54 clinically insignificant 54 somnolence dizziness 54 lipid profiles 54 invasive ductal breast cancer 54 receiving ISENTRESS 54 cholesterol LDL C 54 serum lipids 54 fewer uterine cancers 54 testosterone secretion 54 tHcy concentrations 53 carotid plaque 53 adverse reactions incidence 53 Postnatal depression 53 hyperhomocysteinemia 53 hypopituitarism 53 Hashimoto thyroiditis 53 constipation nausea 53 persistent pulmonary hypertension 53 atherothrombosis 53 Chiuve 53 HOMA scores 53 anovulation 53 x ULN 53 MGUS 53 fasting plasma 53 pravastatin Pravachol 53 REYATAZ r arm 53 BRCA mutations 53 postnatally 53 Postmenopausal 53 schizophrenia schizoaffective disorder 53 colorectal polyp 53 vasomotor symptoms 53 obese postmenopausal 53 mcg kg REBETOL 53 urinary excretion 53 Anxiety disorders 53 SSRI SNRI 53 left ventricular hypertrophy 53 Comorbidities 53 intestinal polyps 53 obesity insulin resistance 53 proliferative retinopathy 53 prescribed antipsychotics 53 metabolic syndrome cluster 53 lymphomas leukemias 53 osteopenic 53 plasma selenium 53 serum retinol 53 menstrual irregularities 53 hepatic fat 53 HPV prevalence 53 osteoporotic fracture 53 albumin excretion rate 53 Skin sterol 53 proteinuria 53 macroalbuminuria 53 neurological abnormalities 53 elevated homocysteine 53 kg m² 53 impulsivity characteristic 53 insulin resistance syndrome 53 inflammatory markers 53 venous blood clots 53 potentially modifiable 53 SUVmax 53 Mood disorders 53 genital ulcer disease 53 LV dysfunction 53 adenotonsillectomy 53 atopic asthma 53 circulating estrogens 53 initiating antiretroviral therapy 53 V Leiden 53 lobular involution 53 nicotine metabolite 53 metabolically healthy 53 nondemented 53 ALT flares 53 testicular cancers 53 calcium excretion 53 esophageal adenocarcinoma 53 oncogenic HPV 53 % Confidence Interval 53 untreated obstructive sleep 53 anemia neutropenia 53 pg ml 53 renal dysfunction 53 comorbidities 53 subfertility 53 mmol liter 53 improves insulin sensitivity 53 Subgroup analysis 53 Comorbid 53 Schaffir 53 thyrotropin 53 phytoestrogen intake 53 apolipoprotein E4 53 RLS symptoms 53 BMI percentiles 53 genital defects 53 lymphocytosis 53 serum urate 53 magnesium intake 53 adolescent females 53 AUDs 53 generalized edema 53 underactive thyroids 53 GBA mutations 53 Psychotropic medications 53 BENICAR HCT 53 tertile 53 perioperative complications 53 postoperative morbidity 53 definite stent thrombosis 53 hypocaloric diet 53 daytime drowsiness 53 cardio vascular disease 53 atherosclerotic cardiovascular disease 53 mass indexes BMIs 53 intact parathyroid hormone 53 dysfunctional voiding 53 triglyceride concentration 53 APOE genotype 53 syncopal 53 inflammatory polyarthritis 53 sUA 53 undescended testicles 53 somatic symptoms 53 renal toxicity 53 muscle protein synthesis 53 TNF antagonist 53 BRCA2 mutation carriers 53 Chlamydia infection 53 initiating HAART 53 elevated TSH 53 serum cotinine levels 53 prostate carcinogenesis 53 premenopause 53 Stroke Risk 53 DVT PE 53 relapsed ALL 53 abstinent alcoholics 53 congenital toxoplasmosis 53 postprandial insulin 53 hormone therapy estrogen 53 fructose intolerant 53 postoperative complication 53 preeclamptic 53 tryptase 53 hypokalemia hypomagnesemia 53 Young Adults CARDIA 53 episodic migraine 53 euthymic 53 severe exacerbations 53 chromosomal disorders 53 hyperkalemia 53 comorbid 53 stone formers 53 inversely associated 53 CI = 53 coinfected patients 53 CrCl 53 abused inhalants 53 abdominal girth 53 diastolic BP 53 univariate analysis 53 lipid lowering agents 53 anal cancers 53 microbleeds 53 lignan intake 53 virological failure 53 Folic acid supplements 53 intraventricular hemorrhage 53 blistering sunburns 53 androgen depletion 53 breast cancer Narod 53 upper gastrointestinal bleeding 53 serum ALT 53 emotional lability 53 pmol L 53 CP CPPS 53 meta regression 53 serum phosphorous 53 primary generalized tonic 53 index BMI 53 hyperlipidaemia 53 atopy 53 Insulin sensitivity 53 genetic syndromes 53 endometrial cancer 53 HeFH 53 nmol L. 53 KIF6 carriers 53 confidence interval CI 53 oral antidiabetic drugs 53 YMRS 53 Proteinuria 53 reflux symptoms 53 preterm delivery 53 multivariate analyzes 53 mU L 53 Grodstein 53 HDL cholesterol triglycerides 53 somnolence fatigue 53 histologic subtype 53 CI #.#-#.# [002] 53 ALDH2 deficient 53 estrogen deficiency 53 dysthymia 53 prenatal exposures 53 incontinence episodes 53 macrovascular disease 53 acute myocardial infarction MI 53 primary biliary cirrhosis 53 Low Testosterone 52 apnea hypopnea index 52 vitamin D insufficiency 52 CLA supplementation 52 uric acid levels 52 recurrent acute pancreatitis 52 homocysteine levels 52 Severe hypoglycemia 52 lupus anticoagulant 52 Vertebral fractures 52 cystatin C 52 ApoE4 gene 52 post transplant lymphoproliferative 52 neurocognitive impairment 52 untreated ADHD 52 virologic failure 52 Prostate Specific Antigen PSA 52 serum LDL cholesterol 52 apoC III 52 bacterial prostatitis 52 mild cognitive impairment 52 adjunctive ABILIFY 52 squamous cell lung cancer 52 latent celiac disease 52 placental malaria 52 esophageal cancers 52 elevated IOP 52 anogenital distance 52 A1C levels 52 severely obese 52 premenopausal women 52 urinary protein 52 receiving TNF blockers 52 Klinefelter syndrome 52 plasma lipids 52 Postoperative complications 52 μg dl 52 Severe Primary IGFD 52 CI #.#-#.# [001] 52 menstrual dysfunction 52 severe hypoglycemia 52 GnRH agonists 52 serum triglycerides 52 HMG CoA reductase inhibitors 52 receiving XGEVA 52 Vitamin D insufficiency 52 allergic sensitization 52 chromosomal abnormalities 52 NIH CPSI 52 related maculopathy 52 liver scarring 52 ovarian hyperstimulation 52 Cholesterol Levels SPARCL 52 Neuroticism 52 conjugated equine estrogen 52 Apgar scores 52 SGOT 52 obstructive coronary artery 52 low birthweights 52 depot medroxyprogesterone acetate 52 SE alleles 52 fructose sweetened beverages 52 lipid concentrations 52 Relapsing remitting MS 52 pooled comparator 52 exploratory endpoints 52 Hospitalizations 52 malignant polyps 52 Prostatitis 52 psychiatric outpatients 52 Heterozygous Familial Hypercholesterolemia 52 retrospective cohort 52 variceal bleeding 52 VADT 52 faulty BRCA genes 52 NOMID 52 myocardial infarctions MIs 52 homozygous familial hypercholesterolemia 52 Suicidal tendencies 52 glycemic index diets 52 asthma hay fever 52 ductal carcinomas 52 thromboembolisms 52 cutaneous melanoma 52 Wisconsin Sleep Cohort 52 alpha carotene 52 microalbumin 52 symptom severity 52 menstrual abnormalities 52 glucose intolerant 52 NNAL 52 artificially sweetened beverages 52 mIU ml